Healthcare Services Group, Inc.
HCSG Healthcare Medical Care Facilities
Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 2.69%, EPS grew 175.0% and free cash flow fell 26.0%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
Follow HCSG
Healthcare Services Group, Inc. (HCSG) EV/Sales
As of 9 October 2026, Healthcare Services Group, Inc. (HCSG) trades at a EV/Sales of 0.7×. Over the past ten years it has ranged from 0.3× (February 2024) to 2.4× (September 2017); the current reading is higher than 32% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | 50.78% |
| FY2024 | 0.4× | 8.86% |
| FY2023 | 0.4× | (18.90%) |
| FY2022 | 0.5× | (29.79%) |
| FY2021 | 0.7× | (32.85%) |
| FY2020 | 1.0× | 13.14% |
| FY2019 | 0.9× | (36.23%) |
| FY2018 | 1.4× | (27.85%) |
| FY2017 | 2.0× | 15.42% |
| FY2016 | 1.7× | 4.06% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.8× | 35.83% |
| Mar 2026 | 0.6× | (8.93%) |
| Dec 2025 | 0.7× | 14.79% |
| Sep 2025 | 0.6× | 5.42% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. compare | 0.2× |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.5× |
| HCSG Healthcare Services Group, Inc. | 0.7× |
| INNV InnovAge Holding Corp. compare | 1.2× |
| PNTG The Pennant Group, Inc. compare | 1.4× |
| NUTX Nutex Health Inc. compare | 1.8× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)